Association of LPA Variants With Risk of Coronary Disease and the Implications for Lipoprotein(a)-Lowering Therapies A Mendelian Randomization Analysis

Author(s):
Burgess, S.; Ference, B.A.; Staley, J.R.; Freitag, D.F.; Mason, A.M.; Nielsen, S.F.; Willeit, P.; Young, R.; Surendran, P.; Karthikeyan, S.; Bolton, T.R.; Peters, J.E.; Kamstrup, P.R.; Tybjaerg-Hansen, A.; Benn, M.; Langsted, A.; Schnohr, P.; Vedel-Krogh, S.; Kobylecki, C.J.; Ford, I.; Packard, C.; Trompet, S.; Jukema, J.W. (0000-0002-3246-8359); Sattar, N.; Angelantonio, E. di; Saleheen, D.; Howson, J.M.M.; Nordestgaard, B.G.; Butterworth, A.S.; Danesh, J.; European Prospective Invest Canc N
Published
2018
Publication type
Article / Letter to editor
Date issued
2018-07-31
Language
English
Is part of
JAMA Cardiology (2018), Vol. 3, no. 7, p. 619-627
hdl
1887/86678
doi
10.1001/jamacardio.2018.1470